2019. 10.24-25.  Leading bio-industry future growth engines AbtironeBio and) LepigeneMD venture companies held a business presentation at the BEXCO Convention Hall in connection with state-of-the-art bio-technology with prominent figures such as medical staff, securities workers and corporate CEOs. AbtironBio has developed and globalized medical lux cosmetics for clinics worldwide and the world's first no-crosslink filler, and researches and develops gene therapy for fourth-generation cancer cells. Through this business presentation, we solved your curiosity and understanding of the overall business through the introduction of  Filler, Medical Skin Care, Car-T, and Q&A.